Abstract
Background
The aim of the study was to analyze the physical activity, dietary, drinking, and smoking habits of schizophrenia patients (SP).
Methods
Data from 194 schizophrenia outpatients collected using sections of the German National Health Interview and Examination Survey were compared with data from the German general population (GP). In addition to univariate data analyses, a multivariate regression analysis was performed.
Results
Schizophrenia patients have a supper snack more frequently, consume instant meals and calorie-reduced food more frequently, and eat healthy groceries more rarely. Though they drink less alcohol, a greater proportion currently smokes, smoking on average 4 cigarettes more per day. On workdays they spend less time with strenuous activities, and in leisure time a greater proportion is involved in no sports. Regression analysis revealed that schizophrenia by itself or in interaction with demographic variables influences physical activity as well as alcohol, nicotine, and healthy grocery consumption. Health habits were particularly disadvantageously affected by schizophrenia in connection with unemployment.
Conclusions
Schizophrenia patients are an appropriate target group for public health interventions. They need information about a healthy diet and motivation to prepare their own meals, to quit smoking, and to exercise.
Similar content being viewed by others
References
Agerbo E, Byrne M, Eaton WW, Mortensen PB (2004) Marital and labor market status in the long run in schizophrenia. Arch Gen Psychiat 61:28–33
Allison DB, Casey DE (2001) Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiat 62(Suppl 7):22–31
Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiat 156:1686–1696
Bernadt MW, Murray RM (1986) Psychiatric disorder, drinking and alcoholism: what are the links? Br J Psychiat 148:393–400
Blanchard JJ, Brown SA, Horan WP, Sherwood AR (2000) Substance use disorders in schizophrenia: review, integration, and a proposed model. Clin Psychol Rev 20:207–234
Brinkhoff T (2004) Citypopulation. http://www.citypopulation.de
Brown S (1997) Excess mortality of schizophrenia. A meta-analysis. Br J Psychiat 171:502–508
Brown S, Birtwistle J, Roe L, Thompson C (1999) The unhealthy lifestyle of people with schizophrenia. Psychol Med 29:697–701
Brown S, Inskip H, Barraclough B (2000) Causes of the excess mortality of schizophrenia. Br J Psychiat 177:212–217
Center for disease control, prevention (2001) Prevalence of healthy lifestyle characteristics – Michigan, 1998 and 2000. Morbidity Mortality Weekly Rep 50:758–761
Connolly M, Kelly C (2005) Lifestyle and physical health in schizophrenia. Adv Psychiat Treat 11:125–132
Daumit GL, Goldberg RW, Anthony C, Dickerson F, Brown CH, Kreyenbuhl J, Wohlheiter K, Dixon LB (2005) Physical activity patterns in adults with severe mental illness. J Nerv Ment Dis 193:641–646
de Leon J (2003) Polydipsia – a study in a long-term psychiatric unit. Eur Arch Psychiatr Clin Neurosci 253:37–39
de Leon J, Diaz FJ, Rogers T, Browne D, Dinsmore L (2002) Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophr Res 56:47–54
de Leon J, Tracy J, McCann E, McGrory A, Diaz FJ (2002) Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophrenia Res 56:55–65
Dickerson FB, Pater A, Origoni AE (2002) Health behaviors and health status of older women with schizophrenia. Psychiatr Serv 53:882–884
Dickey B, Normand SL, Weiss RD, Drake RE, Azeni H (2002) Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv 53:861–867
Dixon L, Weiden P, Delahanty J, Goldberg R, Postrado L, Lucksted A, Lehman A (2000) Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 26:903–912
Elizondo-Armendariz JJ, Guillen Grima F, Aguinaga Ontoso I (2005) Prevalence of physical activity and its relationship to sociodemographic variables and lifestyles in the age 18–65 population of Pamplona, Spain. Rev Esp Salud Publica 79:559–567
Gillis AJ (1993) Determinants of a health-promoting lifestyle: an integrative review. J Adv Nurs 18:345–353
Hughes JR (2002) Rigidity in measures of smoking cessation. Addiction 97:798–799
Hughes JR, McHugh P, Holtzman S (1998) Caffeine and schizophrenia. Psychiatr Serv 49:1415–1417
Johansson L, Thelle DS, Solvoll K, Bjorneboe GE, Drevon CA (1999) Healthy dietary habits in relation to social determinants and lifestyle factors. Br J Nutr 81:211–220
Kelly C, McCreadie R (2000) Cigarette smoking and schizophrenia. Adv Psychiatr Treat 6:327–332
Kumari V, Postma P (2005) Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev 29:1021–1034
Lean ME, Pajonk FG (2003) Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes. Diabetes Care 26:1597–1605
Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, Lonnqvist J (2001) Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiat 58:573–578
Manzoli L, Di Giovanni P, Dragani V, Ferrandino MG, Morano JP, Rauti I, Schioppa F, Romano F, Staniscia T (2005) Smoking behaviour, cessation attempts and the influence of parental smoking in older adult women: a cross-sectional analysis from Italy. Public Health 119:670–678
McChargue DE, Gulliver SB, Hitsman B (2002) Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment? Addiction 97:785–793
McCreadie RG (2003) Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiat 183:534–539
McCreadie RG, Macdonald E, Blacklock C, Tilak-Singh D, Wiles D, Halliday J, Paterson J (1998) Dietary intake of schizophrenic patients in Nithsdale, Scotland: case-control study. BMJ 317:784–785
McEvoy JP (2000) Schizophrenia, substance misuse, and smoking. Curr Opin Psychiat 13:15–19
McEvoy JP, Allen TB (2003) Substance abuse (including nicotine) in schizophrenic patients. Curr Opin Psychiat 16:199–205
Menezes PR, Johnson S, Thornicroft G, Marshall J, Prosser D, Bebbington P, Kuipers E (1996) Drug and alcohol problems among individuals with severe mental illness in south London. Br J Psychiat 168:612–619
Möller H-J, Laux G, Deister A (2001) Psychiatrie und psychotherapie. Thieme Stuttgart
Osby U, Correia N, Brandt L, Ekbom A, Sparen P (2000) Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 45:21–28
Painter J, Rah JH, Lee YK (2002) Comparison of international food guide pictorial representations. J Am Diet Assoc 102:483–489
Paton C, Esop R, Young C, Taylor D (2004) Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs. Acta Psychiatr Scand 110:299–305
Peet M (2004) Diet, diabetes and schizophrenia: review and hypothesis. Br J Psychiat 47:S102–105
Pender NJ, Walker SN, Sechrist KR, Frank-Stromborg M (1990) Predicting health-promoting lifestyles in the workplace. Nurs Res 39:326–332
Pronk NP, Anderson LH, Crain AL, Martinson BC, O’Connor PJ, Sherwood NE, Whitebird RR (2004) Meeting recommendations for multiple healthy lifestyle factors Prevalence, clustering, and predictors among adolescent, adult, and senior health plan members. Am J Prev Med 27:25–33
Rodgers B, Korten AE, Jorm AF, Jacomb PA, Christensen H, Henderson AS (2000) Non-linear relationships in associations of depression and anxiety with alcohol use. Psychol Med 30:421–432
Ryan MC, Collins P, Thakore JH (2003) Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiat 160:284–289
Saari K, Jokelainen J, Veijola J, Koponen H, Jones PB, Savolainen M, Jarvelin MR, Lauren L, Isohanni M, Lindeman S (2004) Serum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey. Acta Psychiatr Scand 110:279–285
Sernyak MJ, Leslie DL, Alarcon RD, Losonczy MF, Rosenheck R (2002) Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiat 159:561–566
Silverstone T, Smith G, Goodall E (1988) Prevalence of obesity in patients receiving depot antipsychotics. Br J Psychiat 153:214–217
Steffen LM, Arnett DK, Blackburn H, Shah G, Armstrong C, Luepker RV, Jacobs DR Jr (2006) Population trends in leisure-time physical activity: Minnesota Heart Survey, 1980–2000. Med Sci Sports Exerc 38:1716–1723
Strassnig M, Brar JS, Ganguli R (2003) Nutritional assessment of patients with schizophrenia: a preliminary study. Schizophr Bull 29:393–397
Tardieu S, Micallef J, Gentile S, Blin O (2003) Weight gain profiles of new anti-psychotics: public health consequences. Obes Rev 4:129–138
Thefeld W, Stolzenberg H, Bellach BM (1999) German national health interview and examination survey: response, composition of participants, and analysis of non-respondents. Gesundheitswesen 61:S57–61
Vieweg WV, Sood AB, Pandurangi A, Silverman JJ (2005) Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain? Acta Psychiatr Scand 111:177–184
von Bothmer MI, Fridlund B (2005) Gender differences in health habits and in motivation for a healthy lifestyle among Swedish university students. Nurs Health Sci 7:107–118
World Health Organisation (1992) The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. World Health Organisation, Geneva
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roick, C., Fritz-Wieacker, A., Matschinger, H. et al. Health habits of patients with schizophrenia. Soc Psychiat Epidemiol 42, 268–276 (2007). https://doi.org/10.1007/s00127-007-0164-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00127-007-0164-5